An Analysis of Gut Bacterial and Fungal Community Interactions in Saxifraga stolonifera Curt.-Treated Mice
Journal Title: Diseases & Research - Year 2023, Vol 3, Issue 2
Abstract
Backgrounds Saxifraga stoloniferaCurt. is valued for its great medicinal potentials, especially for anti-inflammatory activity. The gut microbiome is gradually regarded as a pivotal part that contributes to the therapeutic efficacy of drugs and human health. Yet, research on the modulation of gut bacteria and gut fungi bySaxifraga stoloniferaCurt. is rather scanty, which will hamper the understanding of the anti-inflammatory mechanism ofSaxifraga stoloniferaCurt. Methods To identify the regulatory effect ofSaxifraga stoloniferaCurt. on both gut bacteria and fungi, and gain insights into the interactions between gut bacteria and fungi, we treated C57BL/6 mice with aqueous extract ofSaxifraga stoloniferaCurt. (SSC group, 10 g/kg) and equivalent dose of distilled water (NC group), respectively. After 4 weeks treatment, fecal samples from each mouse were collected and then subjected to full-length 16S rRNA and ITS1/2 gene sequencing. Results As the results shown,Saxifraga stoloniferaCurt. significantly enriched short chain fatty acid (SCFA)-producing bacteria, and reduced the abundance of pro-inflammatory bacteria such asAlistipes. Simultaneously,Saxifraga stoloniferaCurt. increased the level of beneficial fungi such asMortierella kuhlmanii, and decreased the abundance of pathogenic fungi such asFusarium sp.. The correlation network presented a complex interaction between gut bacteria and fungi afterSaxifraga stoloniferaCurt. treatment. Conclusions Altogether, the current study, for the first time, displayed the regulatory effect ofSaxifraga stoloniferaCurt. on gut microbiome, which may be closely related to its pharmacological effects.
Authors and Affiliations
Yanan Yang, Xiaohui Zhao, Linen Zou, Weiying Lu, Xiaopo Zhang, Chongming Wu
Keywords
Related Articles
- EP ID EP740186
- DOI 10.54457/DR.202302003
- Views 28
- Downloads 1
Tumour Microenvironment in Therapy of Metastatic Cancer
GLOBOCAN 2020 has reported that the global cancer burden is 19.3 million cases, with 10 million deaths[1]. The overall survival (OS) after treatment with innovative cancer therapies has not changed for most metastatic ca...
ransient Hypopituitarism in a Patient Developing Diabetic Ketoacidosis after COVID-19: Case Report
Since the beginning of the novel coronavirus disease (COVID-19) pandemic, many papers have been published about the association between COVID-19 and various endocrine abnormalities. Accumulated data so far reveal that hy...
Interferons in Colorectal Cancer Pathogenesis and Therapy
As key modulators of the immune response, interferons play critical roles following infection and during the pathogenesis of cancer. The idea that these cytokines might be developed as new therapies emerged soon after th...
Successful Treatment with CAR- T Cells in a Patient with Immune Thrombocytopenia Associated with Castleman Disease
Multicentric Castleman disease (MCD), a rare lymphoproliferative disorder of incompletely understood etiology, is manifested as enlarged multiple lymph node and multiple organs involvement. The best therapeutic option fo...
Review on Tumour Microenvironment Cell Types Associated with Metastatic Cancer
The Tumour microenvironment (TME) is a highly dynamic and perpetually altering entity of cancer development, progression, invasion, and dissemination. TME is interspersed with cellular components such as immune cells, bl...